OC

Octagon Capital Advisors LP

13F
Octagon Capital Advisors LP
Last update 2025-05-16 35 Stocks (8 new)
Value $517.00 Mil Turnover 27 %
Countries:
Octagon Capital Advisors LP Top Holdings of 2025-03-31 View Full List
Ticker
Company
Shares
Value ($1000)
Shares Change %
Weighting %
Trade Impact %
% of Shares outstanding
3M Change %
YTD Change %
Market Cap $Mil
Industry
NUVB.WS
Nuvation Bio Inc
27,330,800
48,102.2
+8,650.45%
9.310
+9.20%
-
-
-
0
Biotechnology
APLS
Apellis Pharmaceuticals Inc
2,094,000
45,795.8
-30.36%
8.860
-4.79%
1.670
+14.54%
-37.04%
2,525.0
Biotechnology
DNTH
Dianthus Therapeutics Inc
2,341,667
42,477.8
+10.97%
8.220
+0.81%
7.280
+2.64%
-0.05%
700.8
Biotechnology
AVBP
ArriVent BioPharma Inc
2,059,387
38,078.1
0%
7.370
0%
6.020
+1.32%
-19.48%
787.1
Biotechnology
TRVI
Trevi Therapeutics Inc
3,322,000
20,895.4
New Holding
4.040
+4.04%
3.270
+23.46%
+90.29%
954.6
Biotechnology
CNTA
Centessa Pharmaceuticals PLC
1,425,000
20,491.5
-28.50%
3.970
-1.56%
1.070
+13.74%
-7.58%
2,068.4
Biotechnology
GOSS
Gossamer Bio Inc
18,350,000
20,185.0
0%
3.910
0%
8.080
+81.78%
+96.77%
404.6
Biotechnology
OCUL
Ocular Therapeutix Inc
2,425,000
17,775.3
0%
3.440
0%
1.520
+50.89%
+39.58%
1,898.9
Biotechnology
MNMD
Mind Medicine Inc
3,018,000
17,655.3
0%
3.420
0%
3.990
+51.17%
+39.66%
734.4
Biotechnology
COGT
Cogent Biosciences Inc
2,763,000
16,550.4
0%
3.200
0%
2.430
+170.29%
+56.28%
1,699.4
Biotechnology

Octagon Capital Advisors LP's Historical Top Holdings Breakdowns

Octagon Capital Advisors LP's Top Stock Picks View Full List
Ticker
Company
Date
Action
Impact %
Price Range
Price
Price Change from Avrg%
Comment
Current Shares
Share Change
APLS
Apellis Pharmaceuticals Inc
2025-03-31
Reduce
Reduce
-4.79%
21.87 ($27.62) 34.63
$20.09
-27.26%
Reduce -30.36%
2,094,000
-912,980
TRVI
Trevi Therapeutics Inc
2025-03-31
New Buy
New Buy
+4.04%
3.56 ($4.77) 6.81
$7.84
64.36%
New holding
3,322,000
3,322,000
INSM
Insmed Inc
2025-03-31
Sold Out
Sold Out
-3.77%
65.25 ($76.49) 83.83
$103.52
35.34%
Sold Out
0
-332,000
VRNA
Verona Pharma PLC
2025-03-31
Reduce
Reduce
-2.71%
44.81 ($59.82) 69.63
$105.00
75.53%
Reduce -61.97%
217,264
-354,000
TRML
Tourmaline Bio Inc
2025-03-31
New Buy
New Buy
+2.66%
12.21 ($16.03) 21.74
$18.75
16.97%
New holding
905,000
905,000
DYN
Dyne Therapeutics Inc
2025-03-31
Sold Out
Sold Out
-2.59%
10.46 ($14.3) 25.46
$9.24
-35.38%
Sold Out
0
-668,000
MLTX
MoonLake Immunotherapeutics
2025-03-31
New Buy
New Buy
+2.24%
36.75 ($43.09) 53.57
$55.03
27.71%
New holding
296,000
296,000
VSTM
Verastem Inc
2025-03-31
New Buy
New Buy
+2.01%
5.04 ($6.11) 7.53
$5.29
-13.42%
New holding
1,720,000
1,720,000
BBIO
BridgeBio Pharma Inc
2025-03-31
Sold Out
Sold Out
-1.99%
28.12 ($33.72) 37.59
$45.66
35.41%
Sold Out
0
-441,600
CNTA
Centessa Pharmaceuticals PLC
2025-03-31
Reduce
Reduce
-1.56%
14.38 ($16.36) 19.03
$15.48
-5.38%
Reduce -28.5%
1,425,000
-568,052

Octagon Capital Advisors LP Total Holding History ($B)

To

Octagon Capital Advisors LP's Asset Allocation

To

Octagon Capital Advisors LP Past Portfolios

Portfolio Date Number of Stocks New Stocks Total Value ($Mil) Q/Q Turnover

Top Ranked Articles

  • 1

Octagon Capital Advisors LP's Hypothetical Growth since 2025-03-31

Octagon Capital Advisors LP's Yearly Returns

Year Portfolio % % Excess Gain %

Octagon Capital Advisors LP's Holdings Heat Map

Size field:

Octagon Capital Advisors LP's Holdings Bubble Chart

Octagon Capital Advisors LP News

  • 1

Discussions on Octagon Capital Advisors LP

No discussions yet.